Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 1 hour 52 min ago

Kisqali success continues with positive late-stage trial results

01/08/2019
The success marks the second Phase III clinical trial in which Kisqali met overall survival.

Nubeqa bags FDA green light

31/07/2019
The drug has been approved under the governing body’s Priority Review designation.

Eli Lilly announces Verzenio survival benefit

31/07/2019
Breast cancer is the most common cancer in women worldwide, with more than two million new cases diagnosed in 2018.

Neuraxpharm launches first products in UK

31/07/2019
It has also announced the appointment of the company’s new general manager, Craig Bowen.

Biodesix, Immodulon team up for pancreatic cancer treatment

31/07/2019
The partnership will focus on the analysis of the circulating proteome of advanced pancreatic cancer patients treated with IMM-10.

RCGP warns new PM that we ‘cannot risk no-deal disruption’

30/07/2019
Johnson also took a moment in his speech to announced that he wants to revisit and potentially reverse the sugar tax.

52 cases of malaria reported in Scotland

30/07/2019
The figure is an increase of 4% from the 2017 total.

IONTAS, Teva announce new antibody optimisation agreement

30/07/2019
Teva recently halted its Ajovy clinical development.

EMA positive opinion granted for Keytruda combo

30/07/2019
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorisation.

NICE expands draft recommendation for Lokelma

30/07/2019
The news comes shortly after AZ announced positive results from a late-stage trial of the drug.

Finals day location confirmed for the 2019 Marketer of the year competition

30/07/2019
IQVIA have been confirmed to host the finals days for the 2019 PharmaTimes Marketer of the Year and also the Sales Awards at their offices in Reading.

£3m funding for MS, Parkinson’s

29/07/2019
The money will go to a new UK ‘digital brain bank’, Europe’s largest brain and tissue bank, based in London.

AZ presents strong H1 financial results

29/07/2019
The sales numbers were boosted by oncology drugs such as Tagrisso, Imfinzi and Lynparza.

Janssen’s ponesimod holds up against Aubagio in late-stage trial

29/07/2019
The drug is a selective sphingosine-1-phosphate receptor 1 (S1P1) modulator.

First convergent science centre launched in UK

29/07/2019
Scientists are “re-imagining ultrasound technology to develop a treatment that can liquefy cancer cells in the body using microscopic bubbles”.

ViiV submits regulatory application to EMA for investigational HIV combo

29/07/2019
The application is for cabotegravir and Edurant (rilpivirine) as the first monthly, injectable treatment for HIV.

Skin cancer rates rocket 45% in 10 years

29/07/2019
Rates have increased by more than a third (35%) for women and by almost three-fifths (55%) for men.

NHS Confederation responds to PM’s promise to ‘fix crisis’

26/07/2019
But the organisation says it will “need more details of exactly how this will be achieved".

FDA accepts Brinavess resubmission

26/07/2019
The FDA initially cited insufficient data and refused to accept the initial submission in August 2017.

New inquiry into healthy ageing launched

26/07/2019
Increasing health span has been adopted as a policy objective by the UK Government in the Industrial Strategy’s “Ageing Society”.

Pages

X